Washington, D.C. 20549










Date of Report (Date of earliest event reported): July 1, 2019



(Exact name of registrant as specified in its charter)



Delaware 001-38960 83-4388331
(State or other jurisdiction
of incorporation)
File Number)
(I.R.S. Employer
Identification No.)


640 Fifth Avenue, 12th Floor

New York, NY

(Address of principal executive offices) (Zip Code)


(212) 380-7500
(Registrant’s telephone number, including area code)


Not Applicable
(Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 Securities registered pursuant to Section 12(b) of the Act:


Title of each class  Trading Symbol(s)  Name of each exchange on which registered
Units, each consisting of one share of  
Class A common stock,
$0.0001 par value, and one-third of one warrant
  CCX.U  New York Stock Exchange
Shares of Class A common stock  CCX  New York Stock Exchange
Warrants included as part of the units  CCX WS  New York Stock Exchange


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company  x


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨






Item 8.01Other Events.


On July 1, 2019, Churchill Capital Corp II (the “Company”) consummated its initial public offering (the “IPO”) of 69,000,000 units (the “Units”), including the issuance of 9,000,000 Units as a result of the underwriters’ exercise of their over-allotment option. Each Unit consists of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), and one-third of one warrant of the Company (the “Warrants”), each whole warrant entitling the holder thereof to purchase one whole share of Class A Common Stock at a price of $11.50 per share, subject to adjustment as provided in the Company’s registration statement on Form S-1, initially filed with the Securities and Exchange Commission on June 10, 2019 (File No. 333-232057). The Units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $690,000,000.


Simultaneously with the closing of the IPO, the Company completed the private sale (the “Private Placement”) of an aggregate of 15,800,000 warrants (the “Private Placement Warrants”) at a purchase price of $1.00 per Private Placement Warrant, to the Company’s sponsor, Churchill Sponsor II LLC (the “Sponsor”), generating gross proceeds to the Company of $15,800,000. The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO, except that the Sponsor has agreed not to transfer, assign or sell any of the Private Placement Warrants (except to certain permitted transferees) until 30 days after the completion of the Company’s initial business combination. The Private Placement Warrants are also not redeemable by the Company so long as they are held by the Sponsor or its permitted transferees.


A total of $690,000,000 was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. with Continental Stock Transfer & Trust Company acting as trustee. An audited balance sheet as of July 1, 2019 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K.


Item 9.01Financial Statements and Exhibits.


(d)       Exhibits. The following exhibits are filed with this Form 8-K:


  Description of Exhibits
99.1  Audited Balanced Sheet as of July 1, 2019








Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  Churchill Capital Corp II
Date: July 8, 2019 By:  /s/ Peter Seibold
     Name:  Peter Seibold
   Title:  Chief Financial Officer